hydroxychloroquineprednisoloneazathioprinearthritisLupus
…nd addition of azathioprine were predictive of PGA discordance; hydroxychloroquine use was negatively associated with discordance.Conclusions PGA …
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 241–300 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
Oestrogen13Sorafenib13AMIKACIN13Fluorouracil13Duloxetine13Pemetrexed13Norepinephrine13Sertraline13Guselkumab13Tamoxifen13diazepam13Vincristine13Lupus Anticoagulant13Puberty blockers13BEL12FIB-412Gentamicin12Clozapine12Sirolimus12Bempedoic acid12Erenumab12Galcanezumab12Gabapentinoids12Procalcitonin12Allopurinol12Sildenafil12Metamizole12abatacept12pyridostigmine12tremelimumab12Bictegravir12Nifedipine12Sodium-glucose cotransporter-2 inhibitors12Checkpoint inhibitors12Elexacaftor12Wegovy12vasopressors12GLP-1 RA11Tislelizumab11SELADELPAR11IFX11PBO11Voclosporin11ARNI11BCG11PD-L111DAPT11Simvastatin11Exenatide11Denosumab11Everolimus11trametinib11Cannabidiol11Digoxin11Omalizumab11Fluoxetine11LAMA11Mepivacaine11Benzodiazepine11Folic acid11
Articles mentioning drugs
10,506 articles · page 350 of 876hydroxychloroquineazathioprinemycophenolate mofetilClinic of Allergy and ImmunologySystemic lupus erythematosusUniversity Clinical Center of SerbiaSLEAPSInstitute of RheumatologySLE-DAS+1 more
…26]), with median FACIT-Fatigue 32 (18–43). Corticosteroids and hydroxychloroquine were most frequently used (85.5% and 81.7%), followed by azathi…
hydroxychloroquinecyclophosphamidemycophenolic acidsteroidSLElupus
…c, clinical, serological data and treatment histories (steroid, hydroxychloroquine, immunosuppressives) were documented. Comorbid diseases were do…
steroidslupus nephritisANCA-CKDANCA-vasculitisSwedish Renal Registry
…s), had higher eGFR (30 vs 26 mL/min/1.73m 2) and received less steroids (60% vs 66%) but more other immunosuppressive therapy (49% vs 4…
IVIgCSSLE-associated AIHAlupusautoimmune hemolytic anemia(AIHA)SLE
…atients (48 high-dose/pulse,31 moderate,1 low),CS combined with IVIg in 10%, and IVIg alone in 1.1%. An early (first-month) response…
obinutuzumabOBICOVID-19lupus nephritisNCT04221477LN
…renal response at Week 76, with a manageable safety profile for obinutuzumab. This study aimed to further characterise the occurrence of ser…
AnifrolumabSLEsystemic lupus erythematosusSLE-DASSLEDASCOVID-19herpes zosterSpanish rheumatology centers
…Objectives Anifrolumab is a biologic recently approved for systemic lupus erythematosu…
IRF5 inhibitorssystemic lupus erythematosusSLE
…l changes assessed in whole blood and spleen using qPCR.Results IRF5 inhibitors achieved potent, dose-dependent suppression of cytokine release…
cyclophosphamideprednisoneprednisone-equivalentSLE
…y a significant role in extrarenal DM achievement, particularly cyclophosphamide. These results underscore the importance of addressing SDH and …
glucocorticoidsantimalarialsbiologicsimmunosuppressantssystemic lupus erythematosusSLElupus
…uration, depression (BDI-II), anxiety (BAI), and current use of glucocorticoids, antimalarials, immunosuppressants, or biologics. Multilevel Ba…
cenerimodautoimmune diseaseSLENCT03742037systemic lupus erythematosusLupus
…s. The median (IQR) change from baseline was 3.0 (0.8.0) in the cenerimod 4 mg arm and 2.0 (-1.79, 9.0) in the placebo arm. In the subgro…
LAMDALAMDA28lupus arthritisSLEglucocorticoid therapyVisual Analogue Scalerheumatoid arthritis
…8 between known groups. D) Characteristics (95% Cl) of proposed LAMDA thresholds for trial entry, MCII and PASS. E) Characteristics o…